Tela Net Tangible Assets vs Short Long Term Debt Total Analysis
TELA Stock | USD 3.03 0.09 3.06% |
Tela Bio financial indicator trend analysis is much more than just breaking down Tela Bio prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tela Bio is a good investment. Please check the relationship between Tela Bio Net Tangible Assets and its Short Long Term Debt Total accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.
Net Tangible Assets vs Short Long Term Debt Total
Net Tangible Assets vs Short Long Term Debt Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tela Bio Net Tangible Assets account and Short Long Term Debt Total. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Tela Bio's Net Tangible Assets and Short Long Term Debt Total is 0.82. Overlapping area represents the amount of variation of Net Tangible Assets that can explain the historical movement of Short Long Term Debt Total in the same time period over historical financial statements of Tela Bio, assuming nothing else is changed. The correlation between historical values of Tela Bio's Net Tangible Assets and Short Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Tangible Assets of Tela Bio are associated (or correlated) with its Short Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt Total has no effect on the direction of Net Tangible Assets i.e., Tela Bio's Net Tangible Assets and Short Long Term Debt Total go up and down completely randomly.
Correlation Coefficient | 0.82 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Short Long Term Debt Total
Most indicators from Tela Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tela Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.As of November 29, 2024, Selling General Administrative is expected to decline to about 10.6 M. In addition to that, Issuance Of Capital Stock is expected to decline to about 35.7 M
2023 | 2024 (projected) | Depreciation And Amortization | 808K | 850.9K | Interest Income | 3.3M | 2.6M |
Tela Bio fundamental ratios Correlations
Click cells to compare fundamentals
Tela Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tela Bio fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 67.9M | 86.5M | 62.5M | 67.9M | 78.0M | 63.7M | |
Short Long Term Debt Total | 30.2M | 30.8M | 31.5M | 40.3M | 41.1M | 33.0M | |
Other Current Liab | 3.5M | 6.0M | 8.2M | 10.5M | 14.7M | 8.0M | |
Total Current Liabilities | 6.7M | 6.6M | 10.6M | 12.4M | 17.0M | 10.8M | |
Total Stockholder Equity | 31.0M | 49.0M | 20.1M | 14.3M | 18.9M | 19.8M | |
Net Tangible Assets | 28.1M | 46.4M | 17.8M | 11.8M | 13.6M | 14.3M | |
Property Plant And Equipment Net | 677K | 626K | 1.2M | 2.9M | 3.9M | 4.1M | |
Net Debt | (15.1M) | (43.6M) | (12.4M) | (2.1M) | (5.6M) | (5.9M) | |
Retained Earnings | (167.9M) | (196.7M) | (229.9M) | (274.2M) | (320.9M) | (336.9M) | |
Accounts Payable | 3.2M | 652K | 2.4M | 1.5M | 1.7M | 1.6M | |
Cash | 45.3M | 74.4M | 43.9M | 42.0M | 46.7M | 44.2M | |
Non Current Assets Total | 3.6M | 3.2M | 3.5M | 5.4M | 6.3M | 4.3M | |
Non Currrent Assets Other | (3.6M) | (3.2M) | (3.5M) | (5.4M) | 265K | 278.3K | |
Long Term Debt | 30.2M | 30.8M | 31.5M | 39.9M | 40.5M | 32.4M | |
Cash And Short Term Investments | 54.6M | 74.4M | 43.9M | 42.0M | 46.7M | 45.6M | |
Net Receivables | 2.8M | 2.7M | 4.2M | 6.6M | 9.7M | 10.2M | |
Common Stock Shares Outstanding | 11.4M | 12.9M | 14.5M | 16.3M | 22.9M | 14.3M | |
Long Term Debt Total | 31.4M | 30.2M | 31.5M | 39.9M | 45.9M | 30.4M | |
Liabilities And Stockholders Equity | 67.9M | 86.5M | 62.5M | 67.9M | 78.0M | 63.7M | |
Non Current Liabilities Total | 30.2M | 30.8M | 31.9M | 41.1M | 42.2M | 51.4M | |
Inventory | 4.6M | 3.9M | 7.7M | 11.8M | 13.2M | 7.4M | |
Other Current Assets | 2.3M | 4.5M | 6.5M | 2.0M | 2.1M | 2.8M | |
Other Stockholder Equity | 130.9M | 245.7M | 250.1M | 288.4M | 339.7M | 198.1M | |
Total Liab | 37.0M | 37.4M | 42.4M | 53.6M | 59.2M | 59.2M | |
Net Invested Capital | 61.2M | 79.9M | 51.6M | 54.2M | 59.4M | 62.4M | |
Property Plant And Equipment Gross | 677K | 626K | 4.9M | 2.9M | 8.3M | 8.7M | |
Total Current Assets | 64.3M | 83.2M | 59.1M | 62.4M | 71.7M | 59.5M | |
Accumulated Other Comprehensive Income | (19K) | (71K) | (52K) | 150K | 91K | 95.6K | |
Non Current Liabilities Other | 5K | 4K | 380K | 1.2M | 1.7M | 1.8M | |
Net Working Capital | 57.6M | 76.6M | 48.5M | 50.0M | 54.8M | 48.6M | |
Common Stock | 11K | 14K | 15K | 19K | 24K | 15.2K | |
Property Plant Equipment | 677K | 626K | 1.2M | 1.7M | 1.9M | 1.1M | |
Capital Stock | 11K | 14K | 15K | 19K | 24K | 15.2K | |
Intangible Assets | 2.9M | 2.6M | 2.3M | 2.5M | 2.1M | 2.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tela Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tela Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tela Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tela Bio Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tela Bio. If investors know Tela will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tela Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.69) | Revenue Per Share 2.789 | Quarterly Revenue Growth 0.259 | Return On Assets (0.41) | Return On Equity (3.42) |
The market value of Tela Bio is measured differently than its book value, which is the value of Tela that is recorded on the company's balance sheet. Investors also form their own opinion of Tela Bio's value that differs from its market value or its book value, called intrinsic value, which is Tela Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tela Bio's market value can be influenced by many factors that don't directly affect Tela Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tela Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tela Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tela Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.